Compounded Semaglutide
Compare quotes for compounded Semaglutide, see whether a prescription is needed, what affects price, how fast quotes come back, and what happens after you submit.
About Semaglutide
Compounded semaglutide is a GLP-1 receptor agonist available through licensed U.S. 503A/503B pharmacies only when a prescriber documents a specific clinical reason the commercial product (Ozempic, Wegovy, Rybelsus) is not appropriate — for example, a documented allergy to an inactive ingredient or a need for a non-commercial strength. Following the FDA's 2024 resolution of the semaglutide shortage, compounded semaglutide is no longer available for supply or cost reasons. Compounding Finder routes semaglutide quote requests only when clinical eligibility is documented by a licensed prescriber.
Current legal status of compounded semaglutide (2026)
As of 2026, compounded semaglutide is not legal under the shortage-based exception that was in effect in 2022–2024. The FDA declared the semaglutide shortage resolved in late 2024, removing the basis for 503A pharmacies to compound widely distributed copies of Ozempic, Wegovy, or Rybelsus.
Compounding is still permitted on a case-by-case basis under Section 503A when a prescriber documents a specific clinical reason the commercial product is not appropriate for the patient. Cost alone is not a valid basis for compounding. A pharmacy offering widely distributed compounded semaglutide without documented clinical need is operating outside FDA guidance.
When compounded semaglutide is clinically appropriate
Documented clinical reasons that may justify compounded semaglutide include: allergies or intolerances to inactive ingredients in the branded products (phenol, benzyl alcohol, or other excipients); a need for a non-commercial strength to support a titration or tapering protocol that the commercial fixed-dose pens cannot match; or other medically documented circumstances.
Your prescriber must document the reason in your chart and on the prescription. Compounding Finder's pharmacy partners will not fill a compounded semaglutide prescription without that documentation — this is a Section 503A legal requirement, not a company policy.
Commercial semaglutide products — the typical right answer
For most patients, the commercial branded products are the correct choice: Ozempic (FDA-approved for type 2 diabetes), Wegovy (FDA-approved for chronic weight management), and Rybelsus (oral semaglutide for type 2 diabetes). All are manufactured by Novo Nordisk under strict quality controls and covered by many commercial insurance plans for appropriate indications.
Novo Nordisk's NovoCare direct-pay program and the Wegovy and Ozempic Savings Cards can reduce out-of-pocket costs significantly. If your prescriber does not have a documented clinical reason to compound, the commercial product plus manufacturer programs is the appropriate path.
What to expect from Compounding Finder on semaglutide quotes
Compounding Finder accepts semaglutide quote requests, but our pharmacy partners will only fill a prescription where the prescriber has documented clinical eligibility per Section 503A. We do not route quotes for patients seeking compounded semaglutide solely for cost or convenience reasons.
If your provider has documented clinical eligibility, submit a quote request and we'll route it to licensed 503A and 503B compounding pharmacies for price comparison. Otherwise, we recommend working with your provider on the commercial product plus available manufacturer savings programs.
Key Questions Before You Request Quotes
Can I get Semaglutide compounded?
Possibly. A licensed prescriber has to decide whether Semaglutide is appropriate, and a licensed compounding pharmacy has to confirm it can legally prepare the requested strength, form, and quantity.
Is a prescription needed?
Yes. Patient-specific 503A compounding is based on a valid prescription order or prescriber notation for an identified patient.
What affects price?
Strength, dosage form, quantity, ingredient sourcing, sterile versus non-sterile preparation, shipping requirements, and each pharmacy's workflow can all change the final quote.
How fast can I get quotes?
For routable requests, Compounding Finder typically returns quote options by email within 1-2 business days after you submit the request details.
What happens after I submit?
We review the request, route it to eligible licensed pharmacies, collect available options, and email you the quoted choices. You decide whether to move forward with a pharmacy.
Source notes: FDA explains that compounded drugs are not FDA-approved finished products and describes 503A compounding around patient-specific prescriptions. See Compounding and the FDA and Section 503A.
Typical Semaglutide Pricing
Prices vary by dosage, formulation, quantity, and pharmacy. The range above reflects listings currently tracked by Compounding Finder and is not a guaranteed quote. Submit a request below to get a personalized quote for your specific needs.
Related Semaglutide Quote Pages
How to Get Semaglutide Quotes
Semaglutide by State
Compare Semaglutide prices from licensed compounding pharmacies in your state:
Why Compare Semaglutide Prices?
Compounded medication prices vary significantly between pharmacies — sometimes by 300% or more for the exact same drug, strength, and formulation. Factors that affect pricing include the pharmacy’s location, their ingredient sourcing, and compounding volume.
By comparing quotes from multiple licensed pharmacies, you can find the best combination of price, quality, and convenience without spending hours making phone calls.
Frequently Asked Questions
Is compounded semaglutide legal after the FDA shortage resolution?
Compounded semaglutide is legal only on a case-by-case basis under Section 503A — for example, when a prescriber documents that the patient has an allergy to an inactive ingredient in Ozempic or Wegovy, or needs a non-commercial strength for a documented clinical reason. The shortage-based exception that allowed widely distributed compounding in 2022–2023 ended when the FDA declared the semaglutide shortage resolved in late 2024. Cost alone is not a valid basis for compounding.
Can I get compounded semaglutide cheaper than Ozempic or Wegovy?
No — under FDA rules, cost is not a valid clinical reason to compound a drug that is commercially available. A prescriber must document a specific clinical reason for a compounded version to be appropriate. Novo Nordisk's NovoCare program and the Wegovy and Ozempic Savings Cards can reduce out-of-pocket costs for cost-sensitive patients and are the appropriate path — not compounding.
What's the difference between compounded semaglutide and Ozempic?
Ozempic is an FDA-approved branded semaglutide product manufactured by Novo Nordisk under strict quality controls. Compounded semaglutide is prepared by a licensed pharmacist under state pharmacy compounding standards and is not FDA-evaluated for batch safety or efficacy. The active ingredient can be the same, but compounded versions may differ in excipients, concentration, storage requirements, and potency tolerance. Compounded versions should only be used when the commercial branded product is clinically inappropriate for a specific patient.
How do I verify a semaglutide pharmacy is legitimate?
Verify the pharmacy is licensed in your state through your state board of pharmacy, confirm they hold a compounding permit, and ask whether they are inspected by PCAB (Pharmacy Compounding Accreditation Board) or registered as a 503B outsourcing facility. Avoid any seller that ships semaglutide without a prescription, non-U.S. online pharmacies, or any vendor marketing peptides as "research chemicals." Compounding Finder only works with licensed U.S. compounding pharmacies.
Get Free Quotes for Compounded Semaglutide
Free quotes from licensed compounding pharmacies. No account, no obligation. Results in 1–2 business days.